DR. JOHN LUMIR BENDER M.D. NPI 1609864065

NPI Details

DR. John Lumir Bender, M.D. is a family medicine in Fort Collins, CO with 33 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. John Lumir Bender, M.D. NPI is 1609864065. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1992

The provider's business location address is:

4674 SNOW MESA DR
SUITE 140
FORT COLLINS, CO
ZIP 80528-615
Phone: (970) 482-0213
Fax: (970) 482-9646

The NPI 1609864065 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Blood potassium level (HCPCS:84132)
• Blood sodium level (HCPCS:84295)
• Blood creatinine level (HCPCS:82565)
• Blood chloride level (HCPCS:82435)
• Calcium level, total (HCPCS:82310)
• Albumin (protein) level (HCPCS:82040)
• Phosphatase (enzyme) level, alkaline (HCPCS:84075)
• Total protein level, blood (HCPCS:84155)
• Liver enzyme (sgot), level (HCPCS:84450)
• Bilirubin level, total (HCPCS:82247)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Blood glucose (sugar) level (HCPCS:82947)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Automated urinalysis test (HCPCS:81003)
• Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
• Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes (HCPCS:99458)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Vitamin d-3 level (HCPCS:82306)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Screening mammography (HCPCS:77067)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative (HCPCS:86328)
• Hemoglobin a1c level (HCPCS:83036)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
• Detection test by immunoassay technique for influenza virus (HCPCS:87400)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Testing for presence of drug, read by direct observation (HCPCS:80305)
• X-ray of chest, 2 views (HCPCS:71046)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Urine microalbumin (protein) level (HCPCS:82043)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Injection, bamlanivimab and etesevimab, 2100 mg (HCPCS:Q0245)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• X-ray of knee, 4 or more views (HCPCS:73564)
• Creatine kinase (cardiac enzyme) level, mb fraction only (HCPCS:82553)
• Troponin (protein) analysis, quantitative (HCPCS:84484)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Myoglobin (muscle protein) level (HCPCS:83874)
• Magnesium level (HCPCS:83735)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 10/10/2005 and was last updated on 6/18/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.